Leading With Compassion: Chief Minister releases biography of nephrologist H. Sudarshan Ballal
Chief Minister Siddaramaiah on Tuesday released 'Leading with Compassion', a biography of H. Sudarshan Ballal, nephrologist and chairman of Manipal Hospitals.
Authored by Stephen David, this book offers 'an intimate yet universally relevant exploration of leadership through Dr. Ballal's five-decade journey.' More than a traditional biography, this book serves as a vital resource for aspiring medical professionals and leaders globally.
The book that traces Dr. Ballal's early life experiences, navigates through his pivotal professional milestones, highlighting the key decisions and challenges that shaped his career in medicine and leadership. It provides invaluable insights, equipping readers with the wisdom to navigate the intricate and ever-evolving complexities of the medical landscape, both within India and on the global stage.
The foreword for this work has been penned by M.N. Venkatachaliah, Padma Vibhushan awardee and former Chief Justice of India.
Dr. Ballal is known for being among the first in the U.S. to achieve triple board certification in Internal Medicine, Nephrology, and Critical Care. His return to India in the early 1990s marked a pivotal moment for Indian healthcare, as he spearheaded the establishment of Manipal Hospitals' pioneering nephrology programme. Under his leadership, Karnataka witnessed its first cadaver kidney transplant and the inception of its first DNB nephrology programme.
Dr. Ballal said leadership in medicine is not just about titles or technology. 'It is about touching lives with empathy, staying true to your values, and leading by example. I have always believed that compassion is as essential as competence. If this book can inspire even a few young doctors to serve with heart and purpose, then it will have served its goal,' he said.
Apart from the Chief Minister and the former Chief Justice of India, the book release event was attended by N. Santosh Hegde, former Supreme Court Judge and former Lokayukta of Karnataka; Dinesh Gundu Rao, Karnataka's Health Minister, Ranjan R. Pai, Chairman of Manipal Education and Medical Group; C. N. Manjunath, Padma Shri awardee, cardiologist, and Bengaluru Rural MP, H. S. Ballal, Pro Chancellor of Manipal Academy of Higher Education; Dilip Jose, Managing Director and CEO of Manipal Health Enterprises Pvt. Ltd.; K. Govindaraj, MLC and Political Secretary to the Chief Minister of Karnataka; and Sapthami Gowda, actress.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
44 minutes ago
- Hindustan Times
Karnataka reports 87 new Covid-19 cases, active cases rise to 311
Karnataka on Monday reported 87 fresh Covid-19 cases, bringing the state's active caseload to 311, according to the latest bulletin issued by the health department. The 24-hour test positivity rate stood at 17.2 per cent, with 504 tests conducted across the state, including 464 RT-PCR and 40 rapid antigen tests. While the spike may appear significant due to low testing volume, officials emphasized there is no need for public alarm. State Health Minister Dinesh Gundu Rao told PTI that while the current strain appears mild, the government is fully prepared to handle any potential escalation. (Also Read: Students wear masks, follow Covid appropriate behaviour as schools reopens in Karnataka) 'This Covid has got mild infections, not very serious impact. But we are alert, and we have ensured that we are ready for any eventuality,' he said. 'All our infrastructure, oxygen supply, hospital beds, ventilators – is being reviewed and upgraded to respond swiftly if needed.' The minister also stressed that preparedness does not mean panic and urged citizens to stay calm but cautious. Since January 1, four Covid patients with pre-existing comorbidities have died, as per the health department. Authorities continue to monitor the situation closely and advise people to follow standard health precautions, especially vulnerable individuals and those with underlying conditions. As schools across Karnataka prepare to reopen in June, the state government has issued a fresh set of Covid-19 safety guidelines aimed at protecting students, teachers, and staff amid a recent uptick in cases. The decision comes after a high-level review meeting chaired by Chief Minister Siddaramaiah on May 26, in response to rising infections reported across the state. The guidelines, applicable to both government and private institutions, stress early detection, isolation, and preventive care. Schools have been asked to remain vigilant and prioritize the health and safety of their communities. Children showing symptoms like fever, cough, or cold must not be sent to school and should seek immediate medical attention. Re-entry into school is allowed only after full recovery. Schools must monitor students daily and promptly send home any child who develops symptoms during school hours. Parents must be informed without delay if their child falls ill at school. The directive also applies to teachers and non-teaching staff, who are advised to stay home if they feel unwell. The health department emphasized that these measures are precautionary and urged all stakeholders to cooperate in maintaining a safe learning environment. (Also Read: Bengaluru migrant woman caught on camera hitting auto driver with slipper, later apologises. Watch)
Mint
2 hours ago
- Mint
Stocks to watch: Yes Bank, Vodafone Idea, ITC, Adani Group, Grasim Industries among shares in focus today
Yes Bank shares will remain in focus once again today as its board is scheduled to meet to discuss a potential fundraising plan. Vodafone Idea (VIL) stated that it is in discussions with the central government to resolve the AGR matter, with CEO Akshaya Moondra expressing confidence that there is no justification for the government to be restricted in providing relief. Biocon has been granted approval to market the diabetes medication Liraglutide in India. Jindal Stainless announced that it has acquired a 33.64% equity stake in a special purpose vehicle (SPV) formed to build a 282 MW hybrid renewable energy project aimed at powering its manufacturing facilities. On May 28, US-based investment firm GQG Partners boosted its holdings in ITC Ltd, a leading Indian consumer goods company, by executing a bulk deal. HCL Tech revealed a strategic alliance with UiPath aimed at fast-tracking Agentic Automation for businesses worldwide. True North, a private equity firm, along with Niva Bupa Health Insurance CEO Krishnan Ramachandran, sold a total of 10 percent stake in the health insurance company for ₹ 1,507 crore via open market deals. The Adani Group is once again being investigated by the U.S. Department of Justice, according to the Wall Street Journal (WSJ), this time over allegations of importing Iranian liquefied petroleum gas (LPG) into India via the Mundra port. Aditya Birla Group's main holding company revealed that its Finance Committee has given the green light to issue non-convertible debentures (NCDs) totaling up to ₹ 1,000 crore. An Ahmedabad-based firm announced that it has entered into a long-term Sales and Purchase Agreement (SPA) with BP Singapore Pte Ltd, a subsidiary of the global energy giant BP, to supply up to 0.41 million tonnes per annum (MTPA) of liquefied natural gas (LNG) between 2027 and 2036. Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.
Mint
3 hours ago
- Mint
Stocks to trade today: Trade Brains Portal recommends two stocks for 3 June
Stock market today: Indian benchmark indices endured a highly volatile session on Monday, 2 June, but managed to pare early losses and close with modest declines, as late-session buying by bulls helped lift sentiment. The Nifty 50 ended down 0.14% at 24,716, recovering 189 points from the day's low. The Sensex also clawed back from early losses to finish 77 points, or 0.09%, lower at 81,373. Against this backdrop, Trade Brains Portal has picked two stocks—one from the healthcare sector and the other from the finance sector. Stocks to trade today, recommended by Trade Brains Portal for 3 June: Dr. Lal PathLabs Ltd Current price: ₹ 2,777 Target price: ₹3,380 in 16-24 months Stop-loss: ₹ ₹2,475 Why it's recommended: Founded in 1949, Dr. Lal PathLabs is one of India's leading diagnostic chains, offering a comprehensive range of pathology and radiology services. Its pan-India presence includes 12,365 pick-up points (PUPs), 6,607 patient service centers (PSCs), and 298 clinical laboratories as of FY25. The company serves patients and healthcare providers with over 3,100 pathology tests, 1,400+ radiology/cardiology tests, and 385 test panels, operating across more than 23 countries. Key operational strengths include: A logistics backbone supported by 280+ satellite labs and 36 NABL accreditations. Partnerships with 150+ hospitals/labs. A medical team of 250+ physicians and 1,800+ employees. Financial Highlights (FY25) Revenue: ₹2,461 crore, up 10.5% YoY Ebitda: ₹696 crore, up 14.2%, with 28.3% margin PAT: ₹492 crore, up 35.9%, with a 20% net margin The management is guiding for 11–12% revenue growth in FY26, driven by test portfolio expansion and rising patient volumes. Ebitda margins are expected to hover around 27%, as the company invests in growth regions (especially South and West India), digital infrastructure, and talent acquisition. Read this | Dr Lal PathLabs feels margin heat as it chases growth, long-term outlook remains strong Growth Strategy Continued focus on digital expansion, including an AI-based recommendation engine to improve patient experience. Increasing depth in high-growth segments such as genomics, autoimmune disorders, and reproductive diagnostics. Accelerated presence in Tier-3 and Tier-4 cities, particularly in North and East India; 18 new labs added in FY25. Ongoing integration of Suburban Diagnostics (acquired in 2021) to broaden reach and service offerings. Emphasis on volume-led growth by increasing both patient footfall and tests per patient. Actively exploring inorganic growth opportunities through M&A, leveraging its strong brand recall. Risk factors: The accuracy of diagnostic services is critical. Any lapses due to operational errors, poor maintenance, or mishandling could damage reputation and trust. The diagnostic space remains fragmented and highly competitive, with pricing pressure from numerous unorganized players offering similar services. Mahindra & Mahindra Financial Services Ltd Current price: ₹ 260 Target price: ₹ 310 in 16-24 months Stop-loss: ₹ 230 Why it's recommended: Established in 1991, Mahindra Finance is among India's leading non-banking financial companies (NBFCs), catering to a wide customer base across rural and semi-urban India. The company operates a robust pan-India network with over 1,365 branches across 27 states and 7 Union Territories, covering 516,000 villages and 8,000 towns, and serving 11 million customers through 6,000+ dealers and 10 OEM partnerships. Its diverse portfolio spans vehicle loans, SME financing, home finance, insurance broking, mutual funds, personal loans, and fixed deposits, with an AUM of $14.1 billion. Read this | Three multibagger penny stocks to watch out for in 2025 Financial Highlights (FY25) Total disbursements: ₹60,741 crore, up from ₹58,647 crore in FY24 Profit after tax: ₹2,261 crore, up 16% YoY Total income: ₹18,530 crore, up 16% YoY Loan book: ₹1,16,214 crore, up 17% YoY Interest income: ₹16,566 crore, up 15% YoY Interest expenses: ₹8,415 crore, up 21% YoY The company maintained healthy asset quality, supported by a tech-led approach to underwriting and collections. Credit cost stood at 1.3%, net interest margin at 6.5%, and gross stage 3 (GS3) assets at 3.7%. The company maintained healthy asset quality, supported by a tech-led approach to underwriting and collections. Credit cost stood at 1.3%, net interest margin at 6.5%, and gross stage 3 (GS3) assets at 3.7%. Growth Drivers Mahindra Finance has focused on targeting resilient borrowers, digitizing processes via third-party API integrations, and using data analytics to drive collection efficiencies. The company's SME segment saw a 48% jump in disbursements, accounting for 5% of the total. Among vehicles: Passenger cars rose 8%, making up 41% of disbursements Tractor loans grew 3%, contributing 10% Pre-owned and three-wheeler financing accounted for 16% and 4%, respectively Commercial vehicle financing remained stable at 21% Other segments (farm implements, gensets, personal/consumer loans) grew 21%, contributing 2% Mahindra Finance's diversified portfolio and strong brand in rural markets position it well to benefit from increased rural spending and the uptick in auto and SME financing. Risk factors: Credit risk remains a concern, particularly in rural markets, where loan delinquencies could lead to higher NPAs and impact profitability. The company's dependence on multiple funding sources exposes it to liquidity risks, especially during times of financial market stress. Continued performance depends on effective risk management, prudent capital allocation, and strong administrative controls. Market Recap: 2 June Indian benchmark indices ended a volatile session with minor losses on Monday. The Nifty 50 opened at 24,669.70, lower than Friday's close of 24,750.70, and slipped to an intraday low of 24,526.15 before recovering to close at 24,716.60, down 34.10 points or 0.14%. The index remained above its 50-, 100-, and 200-day EMAs, while breaking past the 20-day EMA. Its Relative Strength Index (RSI) stood at 54.70. The Sensex opened at 81,214.42, also below its previous close of 81,451.01, and dipped to a low of 80,654.26 before closing at 81,373.75, down 77.26 points or 0.09%. The Sensex also broke through its 20-day EMA and had an RSI reading of 54.69. Among sectoral indices, PSU banks led the gains on expectations of a possible rate cut at the upcoming RBI policy meeting. The Nifty PSU Bank index jumped 2.43% to 7,145.30, driven by strong moves in Indian Overseas Bank, which climbed 5.42% to ₹42, and Bank of Maharashtra, which rose 6.82% to ₹57.66. Realty stocks also saw strong buying, with the Nifty Realty index rising 2.18% to 970.05. Brigade Enterprises led the pack with a gain of 5.29%. On the other hand, technology stocks underperformed. The Nifty IT index fell 0.69% to 37,063, with names like Mphasis and Persistent Systems losing nearly 2% each. The Nifty Metal index also declined, slipping 0.48% to 9,148.95, after former US President Donald Trump announced plans to double steel import tariffs to 50%. JSW Steel and Lloyds Metals & Energy were among the notable losers, falling 1.25% and 2.76%, respectively. Also read | Amara Raja's March quarter margin is an irritant. More trouble ahead? Asian markets were largely in the red, mirroring the cautious sentiment. Hong Kong's Hang Seng index dropped 0.57% to 23,157.97, while China's Shenzhen Component lost 0.86% to close at 10,040.63. Japan's Nikkei 225 slid 1.3% to 37,470.67. Meanwhile, the Dow Jones in the US managed a modest gain of 0.13% to close at 42,270.07, even as tensions flared between the US and China. Beijing accused Washington of violating the Geneva tariff truce and threatened to raise retaliatory tariffs on US steel and aluminium imports to 50%. Trade Brains Portal is a stock analysis platform. Its trade name is Dailyraven Technologies Pvt. Ltd, and its Sebi-registered research analyst registration number is INH000015729. Investments in securities are subject to market risks. Read all the related documents carefully before investing. Registration granted by Sebi and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Disclaimer: The views and recommendations given in this article are those of individual analysts. These do not represent the views of Mint. We advise investors to check with certified experts before making any investment decisions.
